Andrew Firlik, M.D.
General Partner

Andrew Firlik

Bill Geary

Michael Greeley

Lee Wrubel

Kevin Sharer

Chris Kryder

Tom Mac Mahon

Bob Sheehy

Shoubin Chen

Andrew brings significant experience in neurosurgery, technology development, and company building to Foundation Medical Partners. Prior to joining the firm, he was a venture partner at Sprout Group and managing director of its healthcare technology spinout, New Leaf Venture Partners, and previously, a principal at Canaan Partners. Andrew has led numerous venture capital investments and has helped many early stage companies become successful market leaders. He was a founder (and invented the core technology) of Northstar Neuroscience, which went public in 2006 (NASDAQ: NSTR) and was subsequently acquired by St. Jude Medical (NYSE: STJ). He also served as chairman of IntElect Medical, which was acquired by Boston Scientific (NYSE: BSX).

During more than a decade in the healthcare profession, he published more than 50 medical articles, wrote chapters for several medical textbooks, and was co-editor of a book about cerebrovascular surgery. His scientific work has been presented at many international conferences and he holds numerous patents for his inventions. As a board certified neurosurgeon, he served as clinical assistant professor of neurosurgery at the New York University School of Medicine. He is a member of the Innovation Advisory Board at the Cleveland Clinic and the Cornell Biomedical Engineering Advisory Council, and has served on the Cornell University Council as chairman of the Technology Transfer Committee and member of the Life Sciences Advisory Board.

Andrew earned his M.D. from Cornell University Medical College and his M.B.A. from the University of Pittsburgh after studying biology at Cornell and Oxford University.